MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Catalyst Biosciences PEG Ratio 2011-2026 | CBIO
Annual PEG Ratio Catalyst Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.524 | -0.269 | 0.00243 | -0.109 | 0.0152 | -0.0611 | 0.0228 | -0.0498 | -0.0514 | -0.00696 | -0.013 | -0.0639 | 0.0043 | -0.71 | 0.0971 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0971 | -0.71 | -0.114 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K |  USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.56 | 2.13 % | $ 3.74 B | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
Akebia Therapeutics
AKBA
|
1.02 | $ 1.43 | 3.62 % | $ 368 M | USA |
 |
argenx SE
ARGX
|
0.081 | $ 785.07 | 2.57 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 327.25 | 2.42 % | $ 42.9 B | USA |
 |
Aytu BioScience
AYTU
|
-0.00324 | $ 2.66 | 3.5 % | $ 16.7 M | USA |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.9 | 3.7 % | $ 9.38 B |  Australia |
 |
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 20.4 | -0.87 % | $ 954 M | USA |
 |
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.18 | 1.21 % | $ 447 M | USA |
 |
Avid Bioservices
CDMO
|
0.0439 | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
-0.00298 | - | - | $ 1.41 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.61 | 5.76 % | $ 3.13 B | USA |
 |
Cabaletta Bio
CABA
|
-0.01 | $ 3.09 | 0.65 % | $ 310 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
0.0149 | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.49 | 9.56 % | $ 397 M | Britain |
 |
CTI BioPharma Corp.
CTIC
|
4.94 | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Deciphera Pharmaceuticals
DCPH
|
1.4 | - | - | $ 2.18 B | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | USA |
|
Forte Biosciences
FBRX
|
0.00783 | $ 26.27 | 0.38 % | $ 340 M | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 3.88 | 2.11 % | $ 261 B | Britain |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |